CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY - USD ($) $ in Thousands	Total	Class A Common Stock	Class B Common Stock	Common Stock Class A Common Stock	Common Stock Class B Common Stock	Additional Paid-In Capital	Accumulated Deficit
Balance at beginning of the period at Dec. 31, 2021	$ 447,691			$ 17	$ 3	$ 874,886	$ (427,215)
Balance at beginning of the period (in shares) at Dec. 31, 2021				171,613,049	26,426,937
Increase (Decrease) in Stockholders' Equity
Net loss	(168,723)						(168,723)
Common stock issued upon exercise of stock options and warrants	2,982					2,982
Common stock issued upon exercise of stock options and warrants (in shares)				1,081,313
Common stock issued upon vesting of restricted stock units, net	(106)					(106)
Common stock issued upon vesting of restricted stock units, net (in shares)				1,765,594
Stock-based compensation expense	43,516					43,516
Balance at end of the period at Dec. 31, 2022	325,360			$ 17	$ 3	921,278	(595,938)
Balance at end of the period (in shares) at Dec. 31, 2022				174,459,956	26,426,937
Increase (Decrease) in Stockholders' Equity
Net loss	(133,700)						(133,700)
Common stock issued upon exercise of stock options and warrants	$ 228					228
Common stock issued upon exercise of stock options and warrants (in shares)	180,467			180,467
Common stock issued upon vesting of restricted stock units, net	$ 1			$ 1
Common stock issued upon vesting of restricted stock units, net (in shares)				6,581,371
Stock-based compensation expense	28,164					28,164
Balance at end of the period at Dec. 31, 2023	220,053			$ 18	$ 3	949,670	(729,638)
Balance at end of the period (in shares) at Dec. 31, 2023		181,221,794	26,426,937	181,221,794	26,426,937
Increase (Decrease) in Stockholders' Equity
Net loss	(72,492)						(72,492)
Common stock issued upon exercise of stock options and warrants	$ 64					64
Common stock issued upon exercise of stock options and warrants (in shares)	36,340			36,340
Common stock issued upon vesting of restricted stock units, net	$ (738)			$ 1		(739)
Common stock issued upon vesting of restricted stock units, net (in shares)				6,696,585
Common stock issued for employee stock purchase plan	495					495
Common stock issued for employee stock purchase plan (in shares)				671,435
Stock-based compensation expense	21,450					21,450
Balance at end of the period at Dec. 31, 2024	$ 168,832			$ 19	$ 3	$ 970,940	$ (802,130)
Balance at end of the period (in shares) at Dec. 31, 2024		188,626,154	26,426,937	188,626,154	26,426,937